Epilepsy in neuroacanthocytosis

Neuroacanthocytosis Syndromes

Volumn , Issue , 2005, Pages 117-122

  Meierkord, Hartmut ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548451919     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-2898-9_13     Document Type: Chapter

References (24)

1. Aasly J, Skandsen T, Ro M (1999) Neuroacanthocytosis - the variability of presenting symptoms in two siblings. Acta Neurol Scand 100:322-325.
2. Alvarez-Gomez MJ, Vaamonde J, Narbona J et al (1993) Parkinsonian syndrome in childhood after sodium valproat administration. Clin Neuropharmacol 16:451-455.
3. Commission on Classification and Terminology of the International League Against Epilepsy (1981): Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489-501.
4. Commission on Classification and Terminology of the International League Against Epilepsy (1989): Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399.
5. Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, Kalckreuth W, Watt JM, Corbett AJ, Hamdalla HH, Marshall AG, Sutton I, Dotti MT, Malandrini A, Walker RH, Daniels G, Monaco AP (2001) McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 50:755-764.
6. Dreifuss S, Vingerhoets FJ, Lazeyras F, Andino SG, Spinelli L, Delavelle J, Seeck M (2001) Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy. Neurology 57:1636-1641.
7. Gross DW, Quesney LF, Sadikot AF (1998) Chronic periodic lateralized epileptiform discharges during sleep in a patient with caudate nucleus atrophy: insights into the anatomical circuitry of PLEDs. EEG Clin Neurophysiol 107:434-438.
8. Gutschmidt KU, Stenkamp K, Buchheim K, Heinemann U, Meierkord H (1999) Anticonvulsant actions of furosemide in vitro. Neuroscience 91:1471-1481.
9. Hardie RJ, Pullon H W H, Harding AE, Owen JS, Pires M, Daniels GL, Imai Y, Misra VP, King R H M, Jacobs JM, Tippett P, Duchen LW, Thomas PK, Marsden CD (1991) Neuroacanthocytosis. Brain 114:13-49.
10. Karas BJ, Wilder BJ, Hammond et al (1983) Treatment of valproate tremors. Neurology 33:1380-1382.
11. Kay MM (1991) Band 3 in aging and neurological disease. Ann NY Acad Sci 621:179-204.
12. Kazis A, Kimiskidis V, Georgiadis G, Voloudaki E (1994) Neuroacanthocytosis presenting with epilepsy. 242:415-417.
13. Leppik IE (2001) Issues in the treatment of epilepsy. Epilepsia 42(suppl. 4):1-6.
14. Leppik IE, Gram L, Deaton R et al (1999) Safety of tiagabine: summary of 53 trials. Epilepsy Research 33:235-277.
15. Lombroso CT (1999) Lamotrigine-induced tourettism. Neurology 52:1191-1194.
16. Meierkord H, Shorvon S (1990) Epilepsie bei Neuroakanthozytose. Nervenarzt 61:692-694.
17. Rinne JO, Daniel SE, Scaravilli F, Pires M, Harding AE, Marsden CD (1994) The neuropathological features of neuroacanthocytosis. Mov Dis 9:297-304.
18. Robertson PL, Garofalo EA, Silverstein FS (1993) Carbamazepine-induced tics. Epilepsia 34:965-968.
19. Schwartz MS, Monro PS, Leigh PN (1992) Epilepsy as the presenting feature of neuroacanthocytosis in siblings. J Neurol 239:261.
20. Sramka M, Chkhenkeli SA (1990) Clinical experience in intraoperational determination of brain inhibitory structures and application of implanted neurostimulators in epilepsy. Stereotact Funct Neurosurg 54-55:56-59.
21. Stevenson VL, Hardie RJ (2001) Acanthocytosis and neurological disorders. J Neurol 248:87-94.
22. Troiano AR, Trevisol-Bittencourt PC (1999) Neuroacanthocytosis. A case report. Arq Neuropsiquiatr 57:489-494.
23. Vance JM, Pericak-Vance MA, Bowman MH, Payne CS, Fredane L, Diddique T, Roses AD, Massey EW (1987) Choreo-acanthocytosis: a report of three new families and implications for genetic counselling. Am J Med Genet 28:403-410.
24. Vella N, Ferraro G, Caravaglios G, et al (1991) A feature of caudate control of focal hippocampal epilepsy: evidence for an anterograde pathway. Exp Brain Res 85:240-242.